Pure Global
NCT06115785

Cognitive Stimulation Therapy and Olderly People With Mild Cognitive Impairment

Evaluation of the Effect of Cognitive Stimulation Therapy on Cognitive Status and Apathy in Olderly People With Mild Cognitive Impairment
Ejdane Coskun·ClinicalTrials.gov·behavioralRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Mild Cognitive Impairment
Drug/Device/Intervention
Cognitive Stimulation Therapy
Study type
Interventional
Intervention type
behavioral
Sponsor & location
Primary sponsor
Ejdane Coskun
Funder
Osmaniye Korkut Ata University
Location
Osmaniye, Turkey
Timeline & enrollment
Phase
N/A
Start date
Oct 30, 2023
End date
Dec 25, 2023
Enrollment
60 participants
Primary outcome

Standardized Mini Mental Test (SMMT)

Summary

The aim of this study is to examine the effect of cognitive stimulation therapy on cognitive
 status and apathy in elderly individuals with mild cognitive impairment.

ICD-10 classifications
Mild cognitive disorderAlzheimer diseaseDementia in other specified diseases classified elsewhereDementia in other diseases classified elsewhereDementia in Alzheimer disease
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06115785
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06115785 through Pure Global AI's free database. This phase not specified trial is sponsored by Ejdane Coskun and is currently Recruiting. The study focuses on Mild Cognitive Impairment. Target enrollment is 60 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.